期刊文献+

合肥市54株产CTX-M型ESBLs大肠埃希菌和肺炎克雷伯菌耐药性分析 被引量:5

Study on the resistance in 54 clinical isolates of Klebsiella pneumoniae and Escherichia coli producing CTX-M type extended-spectrum β-lactamases in Hefei
下载PDF
导出
摘要 目的了解合肥市产CTX-M型ESBLs大肠埃希菌和肺炎克雷伯菌耐药性。方法将我省细菌耐药性监控中心保留的54株产CTX-M型ESBLs的临床分离株大肠埃希菌和肺炎克雷伯菌与受体菌E.coliC600进行转移接合试验后,按照2004年NCCLS推荐标准,用琼脂稀释法分别测定野生株和转移接合子对14种不同抗菌药物的MIC,比较并分析两者的不同。结果24株大肠埃希菌和30株肺炎克雷伯菌分别有22株和30株接合成功,野生株的MIC结果显示对哌拉西林、头孢呋辛、头孢曲松钠的耐药率最高,达到100%,对亚胺培南全部敏感;转移接合子的耐药性较野生株有所下降,对氟喹诺酮类的敏感性明显增加。结论合肥市这些菌株所产生的CTX-M型ESBLs对头孢曲松钠和头孢噻肟钠具有超强水解能力,经转移接合试验后,接合子的水解能力有所下降,提示本地区产CTX-M型ESBLs大肠埃希菌和肺炎克雷伯菌中存在着多种耐药机制。 Objective To study the resistance of Klebsiella pneumoniae and Escherichia coli producing CTX-M type extendedspectrum β-lactamases (ESBLs). Methods To obtain the transconjugants of K. pneumoniae and E. coli, 54 clinical strains producing CTX-M ESBLs preserved in Anhui Center for Surveillance of Antimicrobial Resistance mated with the recipient strain E. coli C600. Their resistances to 14 antimicrobial agents were tested by agar dilution method. MICs of the antimicrobial agents against clinical isolates and the transconjugants were determined. Results Conjugation to E. coli C600 was successful in 22 of 24 E. coli strains and 30 of 30 K. pneumoniae strains. All the clinical strains had the same resistant pattern, with the highest resistance rate (100%) to piperacillin, cefuroxime and ceftriaxone. All the strains were susceptible to imipenem. Compared with clinical strains, the transconjugants showed lower resistance to all the antimicrobial agents. The susceptibility to quinolones was apparently higher. Conclusions The E. coli and K. pneumoniae isolates producing CTX-M type ESBLs have super powerful hydrolytic activity against ceftriaxone and eefotaxime in Hefei. The transconjugants shows weaker ability of hydrolysis. The finding suggests that multiple-antimicrobial resistance may be present in these clinical strains.
作者 李慧 李家斌
出处 《中国感染与化疗杂志》 CAS 2006年第2期112-115,共4页 Chinese Journal of Infection and Chemotherapy
基金 国家自然科学基金项目(No.30571654)
关键词 超广谱Β内酰胺酶 抗菌药物 耐药性 Extended spectrum beta-lactamases Antimicrobial agent Drug resistance
  • 相关文献

参考文献8

  • 1李家斌,李惠,李旭,余鑫之,俞云松,马亦林.合肥市产超广谱β-内酰胺酶菌株CTX-M型耐药基因的初步分布[J].中华医院感染学杂志,2004,14(9):965-967. 被引量:14
  • 2李家斌,李旭,苏菲,江晓平,余鑫之,马亦林.合肥市超广谱β-内酰胺酶的类型分布[J].中华传染病杂志,2003,21(2):133-135. 被引量:6
  • 3NCCLS.Performance standards for antimicrobial susceptibility testing,Fourteenth informational supplement[S].NCCLS,Wayne,Pennsylvania,2004,24:1-159.
  • 4Poirel L,Naas TM,Guibert EB,et al.Molecular and biochemical characterization of VEB-1,a novel class A extended-spectrum β-lactamase encoded by an Escherichia coli integron gene[J].Antimicrob Agents Chemother,1999,43:573-581.
  • 5Bonnet R.Growing group of extended-spectrum β-lactamases:the CTX-M enzymes[J].Antimicrob Agents Chemother,2004,48:1-14.
  • 6Bonnet R,Recule C,Baraduc R,et al.Effect of D240G substitution in a novel ESBL CTX-M-27[J].J Antimicrob Chemother,2003,52:29-35.
  • 7Oliver A,Weigel LM,Rasheed JK,et al.Mechanisms of decreased susceptibility to cefpodoxime in Escherichia coli[J].Antimicro Agents Chemother,2002,46:3829-3836.
  • 8Decre D,Burghoffer B,Gaufier V,et al.Outbreak of multi-resistant Klebsiella oxytoca involvin7g strains with extended-spectrum b-lactamases and strains with extended-spectrum activity of the chromosomal β-lactamase[J].J Antimicrob Chemother,2004,54:881-888.

二级参考文献13

  • 1Yan J J, Wu SM, Tsai SH, et al. Prevalence of SHV 12 among clinical isolates of Klebsiella pneumoniae producing extended spectrum beta-lactamases and identification of a novel Amp C enzyme (CMY-8) in Southern Taiwan. Antimicrob Agents Chemother,2000,44: 1438-1442.
  • 2Jacoby GA. Epidemiology of extended-spectrum beta-lactamases.Clin Infect Dis, 1998,27 : 81-83.
  • 3Li JB, Yu YS, Ma YL, et al. Prevalence and analysis of risk factors for infections caused by resistant Escherichia coli strains in Anhui. China Infection,2001,29:228-231.
  • 4Shannon K, Stepleton P, Xiang X, et al. Extended-spectrum betalactamases-producing Klebstella pneumoniae strains causing nosocomial outbreaks of infection in the United Kingdom. J Clin Microbiol, 1998,36 : 3105-3110.
  • 5Gniadkowski M, Schneider I, Jungwirth R, et al. Ceftazidime-resistant Enterobacteriaceae isolates from three Polish hospitals:identification of three novel TEM- and SHV-5-type extended-spectrum beta-lactamases. Antimicrob Agents Chemother, 1998,42514-520.
  • 6Pai H, Lyu S, Lee JH, et al. Survey of extended-spectrum betalactamases in clinical isolates of Escherichla coli and Klebsiella pneumoniae: prevalence of TEM 52 in Korea. J Clin Microbol,1999,37 : 1758-1763.
  • 7Bauernfeind A, Grimm H, Schweighart S. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli[J]. Infection, 1990, 18(5): 294-298.
  • 8Tzouvolekis LS, Tzelepi E, Tassios PT. CTX-M-type β-lactamase: an emerging group of extended-spectrum enzymes[J]. Int J Antimicrob Agents, 2000, 14(2): 137-142.
  • 9National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; ninth informational supplement[S]. NCCLS document M100-S9. 1999.
  • 10Chanawong A, M′ Zali FH, Heritage J, et al. Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People′s Republic of China[J]. Antimicrob Agents Chemother, 2002, 46(3): 630-637.

共引文献18

同被引文献53

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部